+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Head and Neck Cancer Therapeutics Market, By Type (Diagnostic Methods v/s Treatment Type), By Treatment Type (By Disease Indication, By Route of Administration, By Therapeutic Class), By End User, By Region, Company, Opportunities and Forecast, 2027

  • PDF Icon

    Report

  • 358 Pages
  • April 2022
  • Region: Global
  • TechSci Research
  • ID: 5338119
Free Webex Call
10% Free customization

The Global Head and Neck Cancer Therapeutics Market value in the year 2021 was USD2024.33 million that is expected to further grow with a CAGR of 7.22%, during the forecast period, 2023-2027

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Head and Neck Cancer Therapeutics Market value in the year 2021 was USD2024.33 million that is expected to further grow with a CAGR of 7.22%, during the forecast period, 2023-2027, to achieve the market value of USD3126.26 million by 2027F. This impressive growth of the market can be attributed to advancing healthcare industry and majorly the therapeutics sector for the cancer treatments. Increasing instances of cancer like head cancer, throat cancer further drives the growth of the Global Head and Neck Cancer Therapeutics Market in the upcoming five years. Additionally, the market is also bound to experience growth due to advancement in the pharmaceutical industry. Precision medicine are highly implemented when cancer therapeutics is involved. The popularity of the precision medicine along with its specificity toward the cancer treatment of the respective patient being based on type of cancer along with genetic information from the patient enhances the success rates of the procedure therefore supporting the growth of the Global Head and Neck Cancer Therapeutics Market in the next five years. Increased consumption of tobacco and tobacco based products, rapidly increasing smoking habits and alcohol consumption among the population is also contributing to the increasing cases of throat cancer, that leads to the growth of the Global Head and Neck Cancer Therapeutics Market in the future five years.

The Global Head and Neck Cancer Therapeutics Market is majorly segmented by type, end-user, regional distribution, and competition. By type, the market is differentiated into diagnostic methods and treatment type, where segments of the treatment type market are further analyzed by disease indication, route of administration, and therapeutic class. Diagnostic methods is forecast to dominate the market by holding largest revenue shares of the market in the upcoming five years due to increasing demand for the early and efficient diagnosis of the patients suffering from cancer. Treatment for the early stages of cancer is rather feasible and has higher success rate therefore the demand to diagnose the cancer at its early stage drives the growth of the segment along with the growth of the Global Head and Neck Cancer Therapeutics Market in the next five years.

Treatment type segment is forecast to advance in the next five years and account for share of over 41% in 2027 on grounds of increasing advancement in the pharmaceutical and therapeutic sector. Surging demand for the effective treatment for growing instances of cancer further aids the market growth.

Major companies in the Global Head and Neck Cancer Therapeutics Market are Eli Lilly and Company, Bristol Myers Squibb Company, Sanofi S.A., Merck & Co., Inc., Pfizer Inc, AbbVie Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG & Co. KGaA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, AstraZeneca Plc., Astellas Pharma Inc., AB Science SA, Boston Biomedical, Inc., among others.

Years considered for this report:

  • Historical Years: 2017- 2020
  • Base Year: 2021
  • Estimated Year: 2022
  • Forecast Period: 2023 – 2027

Objective of the Study:


  • To analyze the market size of the Global Head and Neck Cancer Therapeutics Market from 2017 to 2020
  • To estimate and forecast the market size of the Global Head and Neck Cancer Therapeutics Market from 2021 to 2022 and growth rate until 2027
  • To classify and forecast the Global Head and Neck Cancer Therapeutics Market based on type, end-user, regional distribution, and competitional landscape
  • To identify dominant region or segment in the Global Head and Neck Cancer Therapeutics Market
  • To identify drivers and challenges for the Global Head and Neck Cancer Therapeutics Market
  • To examine competitive developments such as expansions, new product & service launches, mergers & acquisitions, etc., in the Global Head and Neck Cancer Therapeutics Market
  • To identify and analyze the profile of leading players operating in the Global Head and Neck Cancer Therapeutics Market
  • To identify key sustainable strategies adopted by market players in the Global Head and Neck Cancer Therapeutics Market

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of manufacturers & service providers across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the manufacturers & service providers which could not be identified due to the limitations of secondary research. The publisher Research analyzed the manufacturers & service providers, distribution channels and presence of all major players across the globe.

The publisher calculated the market size of the Global Head and Neck Cancer Therapeutics Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products & services and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the publisher.

Key Target Audience:

  • Manufacturers & service providers, suppliers
  • Distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to head and neck cancer therapeutics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, service providers, suppliers, partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:


In this report, the Global Head and Neck Cancer Therapeutics Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Head and Neck Cancer Therapeutics Market, By Type:

  • Diagnostic Methods
  • Biopsy
  • Imaging
  • Endoscopy
  • Others
  • Treatment Type
  • Surgery
  • Radiation Therapy
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy

Head and Neck Cancer Therapeutics Market, By Treatment Type, By Disease Indication:

  • Lip and Oral Cavity Cancer
  • Laryngeal Cancer
  • Oropharyngeal Cancer
  • Salivary Gland Cancer
  • Nasopharyngeal Cancer
  • Hypopharyngeal Cancer

Head and Neck Cancer Therapeutics Market, By Treatment Type, By Route of Administration:

  • Injectable
  • Oral

Head and Neck Cancer Therapeutics Market, By Treatment Type, By Therapeutic Class:

  • PD Inhibitors
  • EGFR Inhibitors
  • Microtubule Inhibitors

Head and Neck Cancer Therapeutics Market, By End-User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

Head and Neck Cancer Therapeutics Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Singapore
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape


Company Profiles: Detailed analysis of the major companies present in the Global Head and Neck Cancer Therapeutics Market.

Available Customizations:


With the given market data, the publisher offers customizations according to a company’s specific needs. The following customization options are available for the report:
  • Company Information
  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview2. Research Methodology3. Executive Summary
4. Voice of Customer
4.1. Brand Awareness
4.2. Preferred Diagnostic Method
4.3. Preferred Treatment Type
4.4. Preferred Route of Administration
5. Global Head and Neck Cancer Therapeutics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Diagnostic Methods v/s Treatment Type)
5.2.1.1. By Diagnostic Methods (Biopsy, Imaging, Endoscopy, Others)
5.2.1.2. By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Targeted Therapy)
5.2.1.2.1. By Disease Indication (Lip and Oral Cavity Cancer, Laryngeal Cancer, Oropharyngeal Cancer, Salivary Gland Cancer, Nasopharyngeal Cancer, Hypopharyngeal Cancer)
5.2.1.2.2. By Route of Administration (Injectable, Oral)
5.2.1.2.3. By Therapeutic Class (PD Inhibitors, EGFR Inhibitors, Microtubule Inhibitors)
5.2.1.3. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
5.2.2. By Region
5.2.3. By Company (2021)
5.3. Product Market Map
6. North America Head and Neck Cancer Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.1.1. By Diagnostic Methods
6.2.1.2. By Treatment Type
6.2.1.2.1. By Disease Indication
6.2.1.2.2. By Route of Administration
6.2.1.2.3. By Therapeutic Class
6.2.1.3. By End User
6.2.2. By Country
6.3. North America: Country Analysis
6.3.1. United States Head and Neck Cancer Therapeutics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.1.1. By Diagnostic Methods
6.3.1.2.1.2. By Treatment Type
6.3.1.2.1.2.1. By Disease Indication
6.3.1.2.1.2.2. By Route of Administration
6.3.1.2.1.2.3. By Therapeutic Class
6.3.1.2.2. By End User
6.3.2. Canada Head and Neck Cancer Therapeutics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.1.1. By Diagnostic Methods
6.3.2.2.1.2. By Treatment Type
6.3.2.2.1.2.1. By Disease Indication
6.3.2.2.1.2.2. By Route of Administration
6.3.2.2.1.2.3. By Therapeutic Class
6.3.2.2.2. By End User
6.3.3. Mexico Head and Neck Cancer Therapeutics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.1.1. By Diagnostic Methods
6.3.3.2.1.2. By Treatment Type
6.3.3.2.1.2.1. By Disease Indication
6.3.3.2.1.2.2. By Route of Administration
6.3.3.2.1.2.3. By Therapeutic Class
6.3.3.2.2. By End User
7. Europe Head and Neck Cancer Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.1.1. By Diagnostic Methods
7.2.1.2. By Treatment Type
7.2.1.2.1. By Disease Indication
7.2.1.2.2. By Route of Administration
7.2.1.2.3. By Therapeutic Class
7.2.1.3. By End User
7.2.2. By Country
7.3. Europe: Country Analysis
7.3.1. France Head and Neck Cancer Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.1.1. By Diagnostic Methods
7.3.1.2.1.2. By Treatment Type
7.3.1.2.1.2.1. By Disease Indication
7.3.1.2.1.2.2. By Route of Administration
7.3.1.2.1.2.3. By Therapeutic Class
7.3.1.2.2. By End User
7.3.2. Germany Head and Neck Cancer Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.1.1. By Diagnostic Methods
7.3.2.2.1.2. By Treatment Type
7.3.2.2.1.2.1. By Disease Indication
7.3.2.2.1.2.2. By Route of Administration
7.3.2.2.1.2.3. By Therapeutic Class
7.3.2.2.2. By End User
7.3.3. United Kingdom Head and Neck Cancer Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.1.1. By Diagnostic Methods
7.3.3.2.1.2. By Treatment Type
7.3.3.2.1.2.1. By Disease Indication
7.3.3.2.1.2.2. By Route of Administration
7.3.3.2.1.2.3. By Therapeutic Class
7.3.3.2.2. By End User
7.3.4. Italy Head and Neck Cancer Therapeutics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.1.1. By Diagnostic Methods
7.3.4.2.1.2. By Treatment Type
7.3.4.2.1.2.1. By Disease Indication
7.3.4.2.1.2.2. By Route of Administration
7.3.4.2.1.2.3. By Therapeutic Class
7.3.4.2.2. By End User
7.3.5. Spain Head and Neck Cancer Therapeutics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.1.1. By Diagnostic Methods
7.3.5.2.1.2. By Treatment Type
7.3.5.2.1.2.1. By Disease Indication
7.3.5.2.1.2.2. By Route of Administration
7.3.5.2.1.2.3. By Therapeutic Class
7.3.5.2.2. By End User
8. Asia Pacific Head and Neck Cancer Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.1.1. By Diagnostic Methods
8.2.1.2. By Treatment Type
8.2.1.2.1. By Disease Indication
8.2.1.2.2. By Route of Administration
8.2.1.2.3. By Therapeutic Class
8.2.1.3. By End User
8.2.2. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Head and Neck Cancer Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.1.1. By Diagnostic Methods
8.3.1.2.1.2. By Treatment Type
8.3.1.2.1.2.1. By Disease Indication
8.3.1.2.1.2.2. By Route of Administration
8.3.1.2.1.2.3. By Therapeutic Class
8.3.1.2.2. By End User
8.3.2. India Head and Neck Cancer Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.1.1. By Diagnostic Methods
8.3.2.2.1.2. By Treatment Type
8.3.2.2.1.2.1. By Disease Indication
8.3.2.2.1.2.2. By Route of Administration
8.3.2.2.1.2.3. By Therapeutic Class
8.3.2.2.2. By End User
8.3.3. Japan Head and Neck Cancer Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.1.1. By Diagnostic Methods
8.3.3.2.1.2. By Treatment Type
8.3.3.2.1.2.1. By Disease Indication
8.3.3.2.1.2.2. By Route of Administration
8.3.3.2.1.2.3. By Therapeutic Class
8.3.3.2.2. By End User
8.3.4. Australia Head and Neck Cancer Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.1.1. By Diagnostic Methods
8.3.4.2.1.2. By Treatment Type
8.3.4.2.1.2.1. By Disease Indication
8.3.4.2.1.2.2. By Route of Administration
8.3.4.2.1.2.3. By Therapeutic Class
8.3.4.2.2. By End User
8.3.5. South Korea Head and Neck Cancer Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.1.1. By Diagnostic Methods
8.3.5.2.1.2. By Treatment Type
8.3.5.2.1.2.1. By Disease Indication
8.3.5.2.1.2.2. By Route of Administration
8.3.5.2.1.2.3. By Therapeutic Class
8.3.5.2.2. By End User
8.3.6. Singapore Head and Neck Cancer Therapeutics Market Outlook
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Type
8.3.6.2.1.1. By Diagnostic Methods
8.3.6.2.1.2. By Treatment Type
8.3.6.2.1.2.1. By Disease Indication
8.3.6.2.1.2.2. By Route of Administration
8.3.6.2.1.2.3. By Therapeutic Class
8.3.6.2.2. By End User
9. South America Head and Neck Cancer Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.1.1. By Diagnostic Methods
9.2.1.2. By Treatment Type
9.2.1.2.1. By Disease Indication
9.2.1.2.2. By Route of Administration
9.2.1.2.3. By Therapeutic Class
9.2.1.3. By End User
9.2.2. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Head and Neck Cancer Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.1.1. By Diagnostic Methods
9.3.1.2.1.2. By Treatment Type
9.3.1.2.1.2.1. By Disease Indication
9.3.1.2.1.2.2. By Route of Administration
9.3.1.2.1.2.3. By Therapeutic Class
9.3.1.2.2. By End User
9.3.2. Argentina Head and Neck Cancer Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.1.1. By Diagnostic Methods
9.3.2.2.1.2. By Treatment Type
9.3.2.2.1.2.1. By Disease Indication
9.3.2.2.1.2.2. By Route of Administration
9.3.2.2.1.2.3. By Therapeutic Class
9.3.2.2.2. By End User
9.3.3. Colombia Head and Neck Cancer Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.1.1. By Diagnostic Methods
9.3.3.2.1.2. By Treatment Type
9.3.3.2.1.2.1. By Disease Indication
9.3.3.2.1.2.2. By Route of Administration
9.3.3.2.1.2.3. By Therapeutic Class
9.3.3.2.2. By End User
10. Middle East and Africa Head and Neck Cancer Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.1.1. By Diagnostic Methods
10.2.1.2. By Treatment Type
10.2.1.2.1. By Disease Indication
10.2.1.2.2. By Route of Administration
10.2.1.2.3. By Therapeutic Class
10.2.1.3. By End User
10.2.2. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Head and Neck Cancer Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.1.1. By Diagnostic Methods
10.3.1.2.1.2. By Treatment Type
10.3.1.2.1.2.1. By Disease Indication
10.3.1.2.1.2.2. By Route of Administration
10.3.1.2.1.2.3. By Therapeutic Class
10.3.1.2.2. By End User
10.3.2. Saudi Arabia Head and Neck Cancer Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.1.1. By Diagnostic Methods
10.3.2.2.1.2. By Treatment Type
10.3.2.2.1.2.1. By Disease Indication
10.3.2.2.1.2.2. By Route of Administration
10.3.2.2.1.2.3. By Therapeutic Class
10.3.2.2.2. By End User
10.3.3. UAE Head and Neck Cancer Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.1.1. By Diagnostic Methods
10.3.3.2.1.2. By Treatment Type
10.3.3.2.1.2.1. By Disease Indication
10.3.3.2.1.2.2. By Route of Administration
10.3.3.2.1.2.3. By Therapeutic Class
10.3.3.2.2. By End User
11. Clinical Trial Analysis12. Impact of COVID-19 on Global Head and Neck Cancer Therapeutics Market
13. Market Dynamics
13.1. Drivers
13.2. Challenges
14. Market Trends & Developments
15. Competitive Landscape
15.1. Competition Outlook
15.2. Players Profiled
15.2.1. Eli Lilly and Company
15.2.2. Bristol Myers Squibb Company
15.2.3. Sanofi S.A.
15.2.4. Merck & Co., Inc.
15.2.5. Pfizer Inc
15.2.6. AbbVie Inc.
15.2.7. Bayer AG
15.2.8. F. Hoffmann-La Roche Ltd.
15.2.9. Fresenius Medical Care AG & Co. KGaA
15.2.10. Sun Pharmaceutical Industries Ltd.
15.2.11. Teva Pharmaceutical Industries Limited
15.2.12. AstraZeneca Plc.
15.2.13. Astellas Pharma Inc.
15.2.14. AB Science SA
15.2.15. Boston Biomedical, Inc.
16. Strategic Recommendations
List of Figures
Figure 1: Global Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 2: Global Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 3: Global Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 4: Global Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 5: Global Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 6: Global Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 7: Global Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 8: Global Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 9: Global Head and Neck Cancer Therapeutics Market Share, By Region, By Value, 2017-2027F
Figure 10: Global Head and Neck Cancer Therapeutics Market Share, By Company, By Value, 2021
Figure 11: Global Head and Neck Cancer Therapeutics Market Map, By Type, Market Size (USD Million) & Growth Rate (%), 2021
Figure 12: Global Head and Neck Cancer Therapeutics Market Map, By Type, By Diagnostic Methods, Market Size (USD Million) & Growth Rate (%), 2021
Figure 13: Global Head and Neck Cancer Therapeutics Market Map, By Type, By Treatment Type, Market Size (USD Million) & Growth Rate (%), 2021
Figure 14: Global Head and Neck Cancer Therapeutics Market Map, By Treatment Type, By Disease Indication, Market Size (USD Million) & Growth Rate (%), 2021
Figure 15: Global Head and Neck Cancer Therapeutics Market Map, By Treatment Type, By Route of Administration, Market Size (USD Million) & Growth Rate (%), 2021
Figure 16: Global Head and Neck Cancer Therapeutics Market Map, By Treatment Type, By Therapeutic Class, Market Size (USD Million) & Growth Rate (%), 2021
Figure 17: Global Head and Neck Cancer Therapeutics Market Map, By Treatment Type, By End User, Market Size (USD Million) & Growth Rate (%), 2021
Figure 18: Global Head and Neck Cancer Therapeutics Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
Figure 19: North America Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 20: North America Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 21: North America Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 22: North America Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 23: North America Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 24: North America Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 25: North America Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 26: North America Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 27: North America Head and Neck Cancer Therapeutics Market Share, By Country, By Value, 2017-2027F
Figure 28: United States Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 29: United States Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 30: United States Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 31: United States Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 32: United States Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 33: United States Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 34: United States Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 35: United States Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 36: Canada Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 37: Canada Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 38: Canada Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 39: Canada Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 40: Canada Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 41: Canada Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 42: Canada Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 43: Canada Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 44: Mexico Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 45: Mexico Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 46: Mexico Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 47: Mexico Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 48: Mexico Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 49: Mexico Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 50: Mexico Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 51: Mexico Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 52: Europe Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 53: Europe Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 54: Europe Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 55: Europe Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 56: Europe Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 57: Europe Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 58: Europe Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 59: Europe Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 60: Europe Head and Neck Cancer Therapeutics Market Share, By Country, By Value, 2017-2027F
Figure 61: France Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 62: France Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 63: France Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 64: France Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 65: France Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 66: France Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 67: France Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 68: France Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 69: Germany Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 70: Germany Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 71: Germany Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 72: Germany Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 73: Germany Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 74: Germany Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 75: Germany Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 76: Germany Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 77: United Kingdom Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 78: United Kingdom Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 79: United Kingdom Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 80: United Kingdom Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 81: United Kingdom Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 82: United Kingdom Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 83: United Kingdom Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 84: United Kingdom Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 85: Italy Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 86: Italy Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 87: Italy Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 88: Italy Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 89: Italy Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 90: Italy Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 91: Italy Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 92: Italy Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 93: Spain Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 94: Spain Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 95: Spain Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 96: Spain Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 97: Spain Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 98: Spain Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 99: Spain Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 100: Spain Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 101: Asia Pacific Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 102: Asia Pacific Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 103: Asia Pacific Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 104: Asia Pacific Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 105: Asia Pacific Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 106: Asia Pacific Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 107: Asia Pacific Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 108: Asia Pacific Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 109: Asia Pacific Head and Neck Cancer Therapeutics Market Share, By Country, By Value, 2017-2027F
Figure 110: China Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 111: China Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 112: China Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 113: China Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 114: China Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 115: China Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 116: China Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 117: China Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 118: India Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 119: India Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 120: India Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 121: India Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 122: India Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 123: India Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 124: India Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 125: India Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 126: Japan Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 127: Japan Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 128: Japan Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 129: Japan Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 130: Japan Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 131: Japan Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 132: Japan Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 133: Japan Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 134: Australia Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 135: Australia Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 136: Australia Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 137: Australia Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 138: Australia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 139: Australia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 140: Australia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 141: Australia Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 142: South Korea Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 143: South Korea Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 144: South Korea Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 145: South Korea Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 146: South Korea Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 147: South Korea Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 148: South Korea Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 149: South Korea Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 150: Singapore Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 151: Singapore Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 152: Singapore Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 153: Singapore Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 154: Singapore Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 155: Singapore Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 156: Singapore Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 157: Singapore Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 158: South America Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 159: South America Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 160: South America Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 161: South America Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 162: South America Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 163: South America Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 164: South America Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 165: South America Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 166: South America Head and Neck Cancer Therapeutics Market Share, By Country, By Value, 2017-2027F
Figure 167: Brazil Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 168: Brazil Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 169: Brazil Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 170: Brazil Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 171: Brazil Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 172: Brazil Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 173: Brazil Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 174: Brazil Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 175: Argentina Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 176: Argentina Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 177: Argentina Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 178: Argentina Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 179: Argentina Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 180: Argentina Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 181: Argentina Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 182: Argentina Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 183: Colombia Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 184: Colombia Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 185: Colombia Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 186: Colombia Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 187: Colombia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 188: Colombia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 189: Colombia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 190: Colombia Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 191: Middle East & Africa Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 192: Middle East & Africa Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 193: Middle East & Africa Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 194: Middle East & Africa Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 195: Middle East & Africa Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 196: Middle East & Africa Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 197: Middle East & Africa Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 198: Middle East & Africa Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 199: Middle East & Africa Head and Neck Cancer Therapeutics Market Share, By Country, By Value, 2017-2027F
Figure 200: South Africa Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 201: South Africa Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 202: South Africa Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 203: South Africa Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 204: South Africa Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 205: South Africa Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 206: South Africa Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 207: South Africa Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 208: Saudi Arabia Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 209: Saudi Arabia Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 210: Saudi Arabia Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 211: Saudi Arabia Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 212: Saudi Arabia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 213: Saudi Arabia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 214: Saudi Arabia Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 215: Saudi Arabia Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 216: UAE Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2017-2027F
Figure 217: UAE Head and Neck Cancer Therapeutics Market Share, By Type, By Value, 2017-2027F
Figure 218: UAE Head and Neck Cancer Therapeutics Market Share, By Type, By Diagnostic Methods, By Value, 2017-2027F
Figure 219: UAE Head and Neck Cancer Therapeutics Market Share, By Type, By Treatment Type, By Value, 2017-2027F
Figure 220: UAE Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Disease Indication, By Value, 2017-2027F
Figure 221: UAE Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Route of Administration, By Value, 2017-2027F
Figure 222: UAE Head and Neck Cancer Therapeutics Market Share, By Treatment Type, By Therapeutic Class, By Value, 2017-2027F
Figure 223: UAE Head and Neck Cancer Therapeutics Market Share, By End User, By Value, 2017-2027F
Figure 224: Clinical Trials Studies on Head and Neck Cancer Therapeutics, 2017 and 2021
List of Tables
Table 1: Global Cancer Statistics, 2020
Table 2: Total Number of New Cancer Cases and Deaths Reported Globally, By Type, 2020
Table 3: North America Cancer Statistics, 2020
Table 4: Total Number of New Cancer Cases and Deaths Reported in North America, By Type, 2020
Table 5: Europe Cancer Statistics, 2020
Table 6: Total Number of New Cancer Cases and Deaths Reported in Europe, By Type, 2020
Table 7: Asia-Pacific Cancer Statistics, 2020
Table 8: Total Number of New Cancer Cases and Deaths Reported in Asia Pacific, By Type, 2020
Table 9: South America Cancer Statistics, 2020
Table 10: Total Number of New Cancer Cases and Deaths Reported in South America, By Type, 2020
Table 11: Middle East & Africa Cancer Statistics, 2020
Table 12: Total Number of New Cancer Cases and Deaths Reported in Middle East, By Type, 2020
Table 13: Clinical Trial Studies on Head and Neck Cancer Therapeutics, 2021

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Eli Lilly and Company
  • Bristol Myers Squibb Company
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Pfizer Inc
  • AbbVie Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Limited
  • AstraZeneca Plc.
  • Astellas Pharma Inc.
  • AB Science SA
  • Boston Biomedical, Inc.